Home | Welcome to Contract Pharma   
Last Updated Friday, July 25 2014
Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published June 3, 2014
U.S. biopharma has a good image, according to APCO’s latest study, but proactive attention to policymakers and healthcare providers may be helpful Read More »
Will Cell-Based Therapy Shape Biopharma’s Future?
Published June 3, 2014
Pluristem’s CEO, Zami Aberman, compares the state of stem cell research today to where antibodies were 20 years ago. Clinical evidence is key to moving the technology forward, he says. Read More »
Published April 4, 2014
Will be used to enhance infectious disease development program Read More »
By Kristin Brooks
Published February 14, 2014
To provide preclinical drug development through to Phase I - IV trials Read More »
By Kristin Brooks
Published February 14, 2014
Hoffman brings more than 25 years of experience Read More »
By Dr Laura Ciccolini, Commercial Director
BTL provides contract research and development, consultancy services, training and advanced instrumentation to the global biopharmaceutical and related industries. We have decades of experience in the application of all aspects of freeze drying techn… Read More »
By Hans Klingenberg
By Jennifer Marcum, CEO
The Top 10 Biopharmaceutical Companies
By Gil Y. Roth
Published July 14, 2011
Our annual look at the 10 biggest biopharmaceutical players Read More »
2010 Top 10 Biopharmaceutical Companies Report
By Gil Roth
Published July 9, 2010
Our rules for inclusion on the Top 10 Biopharma list are as follows: you’re a biopharma company if more than half of your drug revenues — not royalties — come from large-molecule drugs and vaccines. It’s arbitrary, but it&rs… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On